Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Investor Grants Warnex Three Months to Repay $500K

NEW YORK (GenomeWeb News) – The genetic testing, molecular diagnostics, and lab services company Warnex said today it has been granted a waiver from an investor for the repayment of $500,000 it owes as a quarterly capital investment payment that was due today. 
 
Warnex said SIPAR, a Montreal-based investment company, has given it until April 1 to make this payment. Warnex also said the agreement is part of a strategy it announced last month to restructure its debts and reorganize its financing in order to stabilize its balance sheet.
 
Warnex CEO Mark Busgang said the agreement shows SIPAR’s “confidence in our ability to reorganize our financial instruments.”

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more